Resensitization of methicillin-resistant Staphylococcus aureus by amoxapine, an FDA-approved antidepressant

The rapid increase in bacterial resistance to antibiotics is a global healthcare crisis. Non-antibiotic pharmaceuticals that have attained approval by the United States Food and Drug Administration have the potential to be repurposed as bacterial resistance-modifying agents and therefore could becom...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Tyler J., Blackledge, Meghan S., Vigueira, Patrick A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767979/
https://www.ncbi.nlm.nih.gov/pubmed/29349359
http://dx.doi.org/10.1016/j.heliyon.2017.e00501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767979/
https://www.ncbi.nlm.nih.gov/pubmed/29349359
http://dx.doi.org/10.1016/j.heliyon.2017.e00501

Ejemplares similares